The global urinary incontinence market size is expected to reach USD 4.53 Billion in 2028 at a CAGR of 7.6% during the forecast period, according to the latest report by Reports and Data. Increasing incidence of urinary incontinence (UI) among women across the globe, technological advancements in urinary incontinence devices, improvements in health policies and insurance coverage, and growing awareness among patients regarding severity of the medical condition are key factors expected to drive market revenue growth over the forecast period. In addition, development of advanced surgical and non-invasive therapies, availability of wide range of treatment modalities for urinary incontinence, and rising number of initiatives to raise awareness of UI are some other key factors expected to further fuel revenue growth of the market going ahead.
Urinary incontinence is a common and distressing medical condition and is defined as involuntary or abnormal urine loss caused due to lower urinary tract dysfunction, chronic conditions, or medications. Urinary incontinence can have serious negative effects on physical function, psychological health, and quality of life for patients. It can limit mobility of patients and social interactions and can lead to depression in severe cases. Neglected urinary incontinence can lead to systemic infections, skin problems, and skin wounds, which further adds other physical morbidities to patients who are already suffering from numerous symptoms. Urinary incontinence is recognized as a priority health issue by the World Health Organization and has emphasized the need for proper attention from all healthcare providers to develop effective management techniques for urinary incontinence. It also poses a significant economic burden to the individual and healthcare system, and this has further boosted demand for robust treatment options, UI-specific tools to enhance patient outcomes, and introduction of advanced surgical interventions. This can, in turn, fuel revenue growth of the market going ahead.
Treatment of incontinence can vary with the type of incontinence, which makes it important to accurately identify the specific type of incontinence. Urinary incontinence is classified into three main types: stress UI, urge UI, and mixed UI. In recent years, treatment options for stress and urge urinary incontinence have advanced and aim to prevent involuntary loss of urine caused due to increased intra-abdominal pressure occurring during physical activity. Advancements in and rapid adoption of non-surgical therapies such as behavioral therapy and drug therapy are some other factors expected to drive market growth. However, lack of awareness about available treatment modalities, absence of favorable reimbursement policies in developing countries, and social stigma surrounding this condition are some key factors that can hamper market growth to a certain extent going ahead.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/2741
Major companies profiled in the market report include Covidien plc (Medtronic), Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc., Cook Medical, Prosurg, Inc., and Cogentix Medical Inc.
Some Key Highlights from the Report:
- Stress incontinence segment is expected to account for largest revenue share over the forecast period, attributable to increasing incidence of stress urinary incontinence among women, advancements in conservative therapies for stress UI, and rise in number of people opting for treatment for stress incontinence.
- Neuromodulation segment is expected to dominate other devices segments in terms of revenue growth over the forecast period, attributable to increasing adoption of neuromodulative therapies for treatment of urinary incontinence, technological advancements in neuromodulation devices, and increasing importance of neuromodulation therapies in urology.
- Hospital segment is expected to register significant revenue growth over the forecast period, attributable to increasing availability of advanced treatment approaches such as neuromodulation devices in hospital settings, rising number of patients opting for surgical therapies for urinary incontinence, and availability of skilled professionals.
- North America is expected to account for largest revenue share over the forecast period, attributable to increasing prevalence of urinary incontinence in the United States and Canada, growing geriatric population, rising number of regulatory approvals for incontinence devices, growing popularity of at-home treatments, and favorable reimbursement policies in the region.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/urinary-incontinence-market
For the purpose of this report, Reports and Data has segmented the urinary incontinence market based on type, devices, end use, and region:
Type Outlook (Revenue, USD Billion, 2018-2028)
- Urge Incontinence
- Overflow Incontinence
- Stress Incontinence
- Functional Incontinence
- Mixed Urinary Incontinence
- Total Incontinence
- Others
Devices Outlook (Revenue, USD Billion; 2018-2028)
- Electrical Stimulation Devices
- Non-implantable
- Implantable
- Urethral Bulking Agents
- Urinary Catheters
- Foley
- Antimicrobial Foley Catheters
- Suprapubic
- Intermittent
- Neuromodulation Devices
- Others
End Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Use
- Others
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/2741
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs
